KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) EBITDA Margin: 2009-2025

Historic EBITDA Margin for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to -3.00%.

  • Exact Sciences' EBITDA Margin rose 256.00% to -3.00% in Q3 2025 from the same period last year, while for Sep 2025 it was -32.45%, marking a year-over-year decrease of 2353.00%. This contributed to the annual value of -38.01% for FY2024, which is 2941.00% down from last year.
  • Exact Sciences' EBITDA Margin amounted to -3.00% in Q3 2025, which was down 1,033.81% from -0.26% recorded in Q2 2025.
  • Over the past 5 years, Exact Sciences' EBITDA Margin peaked at 1.09% during Q3 2023, and registered a low of -122.84% during Q4 2024.
  • For the 3-year period, Exact Sciences' EBITDA Margin averaged around -18.21%, with its median value being -10.49% (2023).
  • Its EBITDA Margin has fluctuated over the past 5 years, first soared by 4,225bps in 2021, then slumped by 11,235bps in 2024.
  • Quarterly analysis of 5 years shows Exact Sciences' EBITDA Margin stood at -46.74% in 2021, then skyrocketed by 2,524bps to -21.50% in 2022, then soared by 1,101bps to -10.49% in 2023, then slumped by 11,235bps to -122.84% in 2024, then soared by 256bps to -3.00% in 2025.
  • Its EBITDA Margin was -3.00% in Q3 2025, compared to -0.26% in Q2 2025 and -13.58% in Q1 2025.